BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28283827)

  • 1. Prenatal ultrasound, genotype, and outcome in a large cohort of prenatally affected patients with autosomal-recessive polycystic kidney disease and other hereditary cystic kidney diseases.
    Erger F; Brüchle NO; Gembruch U; Zerres K
    Arch Gynecol Obstet; 2017 Apr; 295(4):897-906. PubMed ID: 28283827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal ultrasound in fetuses with polycystic kidney appearance - expanding the diagnostic algorithm.
    Simonini C; Fröschen EM; Nadal J; Strizek B; Berg C; Geipel A; Gembruch U
    Arch Gynecol Obstet; 2023 Oct; 308(4):1287-1300. PubMed ID: 36310336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
    Tutal O; Gulhan B; Atayar E; Yuksel S; Ozcakar ZB; Soylemezoglu O; Saygili S; Caliskan S; Inozu M; Baskin E; Duzova A; Hayran M; Topaloglu R; Ozaltin F
    Nephron; 2024; 148(5):319-332. PubMed ID: 36657418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.
    Gunay-Aygun M; Turkbey BI; Bryant J; Daryanani KT; Gerstein MT; Piwnica-Worms K; Choyke P; Heller T; Gahl WA
    Mol Genet Metab; 2011 Dec; 104(4):677-81. PubMed ID: 21945273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MKS3-related ciliopathy with features of autosomal recessive polycystic kidney disease, nephronophthisis, and Joubert Syndrome.
    Gunay-Aygun M; Parisi MA; Doherty D; Tuchman M; Tsilou E; Kleiner DE; Huizing M; Turkbey B; Choyke P; Guay-Woodford L; Heller T; Szymanska K; Johnson CA; Glass I; Gahl WA
    J Pediatr; 2009 Sep; 155(3):386-92.e1. PubMed ID: 19540516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atmin modulates Pkhd1 expression and may mediate Autosomal Recessive Polycystic Kidney Disease (ARPKD) through altered non-canonical Wnt/Planar Cell Polarity (PCP) signalling.
    Richards T; Modarage K; Dean C; McCarthy-Boxer A; Hilton H; Esapa C; Norman J; Wilson P; Goggolidou P
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):378-390. PubMed ID: 30414501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-parametric MRI of kidney disease progression for autosomal recessive polycystic kidney disease: mouse model and initial patient results.
    MacAskill CJ; Erokwu BO; Markley M; Parsons A; Farr S; Zhang Y; Tran U; Chen Y; Anderson CE; Serai S; Hartung EA; Wessely O; Ma D; Dell KM; Flask CA
    Pediatr Res; 2021 Jan; 89(1):157-162. PubMed ID: 32283547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal renal cystic disease and post-natal follow up-a single center experience.
    Botero-Calderon L; Lawrence A; O'Toole N; Guay-Woodford LM
    Front Pediatr; 2023; 11():1243504. PubMed ID: 37635794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant Liver Cystic Disease in a New Heterozygotic PKHD1 Variant: A Case Report.
    Van Buren JD; Neuman JT; Sidlow R
    Am J Case Rep; 2023 Jan; 24():e938507. PubMed ID: 36691356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ARPKD mouse model with near-complete deletion of the Polycystic Kidney and Hepatic Disease 1 (Pkhd1) genomic locus presents with multiple phenotypes but not renal cysts.
    Ishimoto Y; Menezes LF; Zhou F; Yoshida T; Komori T; Qiu J; Young MF; Lu H; Potapova S; Outeda P; Watnick T; Germino GG
    Kidney Int; 2023 Sep; 104(3):611-616. PubMed ID: 37419448
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease.
    Liebau MC; Hartung EA; Perrone RD
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1551-1554. PubMed ID: 35998973
    [No Abstract]   [Full Text] [Related]  

  • 12. Autosomal Recessive Polycystic Kidney Disease: Diagnosis, Prognosis, and Management.
    Burgmaier K; Broekaert IJ; Liebau MC
    Adv Kidney Dis Health; 2023 Sep; 30(5):468-476. PubMed ID: 38097335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Clinical Presentations and Renal Outcome in Neonates With Autosomal Recessive Polycystic Kidney Disease.
    Khin E; Ramdas D
    Cureus; 2024 May; 16(5):e59993. PubMed ID: 38854310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
    Sekine A; Hidaka S; Moriyama T; Shikida Y; Shimazu K; Ishikawa E; Uchiyama K; Kataoka H; Kawano H; Kurashige M; Sato M; Suwabe T; Nakatani S; Otsuka T; Kai H; Katayama K; Makabe S; Manabe S; Shimabukuro W; Nakanishi K; Nishio S; Hattanda F; Hanaoka K; Miura K; Hayashi H; Hoshino J; Tsuchiya K; Mochizuki T; Horie S; Narita I; Muto S
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.
    Hartung EA; Guay-Woodford LM
    Pediatrics; 2014 Sep; 134(3):e833-45. PubMed ID: 25113295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic spectrum of polycystic kidney disease in children.
    Kocaaga A; Atikel YÖ; Sak M; Karakaya T
    Rev Assoc Med Bras (1992); 2023; 69(11):e20230334. PubMed ID: 37909612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal ciliopathies: promising drug targets and prospects for clinical trials.
    Devlin L; Dhondurao Sudhindar P; Sayer JA
    Expert Opin Ther Targets; 2023; 27(4-5):325-346. PubMed ID: 37243567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.
    Mekahli D; Liebau MC; Cadnapaphornchai MA; Goldstein SL; Greenbaum LA; Litwin M; Seeman T; Schaefer F; Guay-Woodford LM
    BMC Nephrol; 2023 Feb; 24(1):33. PubMed ID: 36782137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management.
    Hanna C; Iliuta IA; Besse W; Mekahli D; Chebib FT
    Semin Nephrol; 2023 Jul; 43(4):151434. PubMed ID: 37996359
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.